Jennifer Fox

Since 1992, Bradenton Research Center has completed over 150 clinical research studies. The diseases we’ve studied include Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Influenza, Migraines, Neuropathic Pain, Gout, Hypertension, Stroke, Type 2 Diabetes, Diabetic Neuropathy, Epilepsy, COVID-19, and many others. Led by Medical Director Eric Folkens, MD, our research team has more than 30 years of …

LEARN MORE ABOUT GETTING INVOLVED IN CLINICAL RESEARCH TRIALS Read More »

Learn more about getting involved in clinical trials. Receive compensation and free medical care, while helping with the advancements of medical research. For researchers who conduct clinical trials, enrolling enough patients to make a trial meaningful is always a challenge. Enrolling a single patient in a study often requires not one but two participants, the …

NEW MEDICAL ADVANCEMENT FOR TREATING ALZHEIMER’S AND PARKINSON’S DISEASE Read More »

Clinical trials are medical research studies involving patients. They can help discover new medicines, or get improved versions of existing medicines. The main objective of a clinical research study is to answer questions about the safety and effectiveness of these potential new medications. These studies must be completed before a new treatment can be offered …

WHAT WOULD MEDICINE BE LIKE WITHOUT THE CLINICAL TRIALS WE HAVE TODAY? Read More »

Are you or someone you know struggling with memory loss? Are everyday tasks becoming more difficult? Alzheimer’s disease typically progresses slowly in three general stages: early or mild, middle (moderate) and late-stage, meaning more severe. Since Alzheimer’s affects people in different ways, each person may experience symptoms, or progress through these stages, differently. Mood changes …

LEARN MORE ABOUT THIS NEW ALZHEIMER’S DISEASE TREATMENT OPTION Read More »

As we grow older, we may experience physiological changes that can cause glitches in brain functions we’ve always taken for granted. Maybe, it takes longer to learn and recall new information. Or, maybe, you’ve noticed you’re just not as quick as you used to be. In fact, we could even mistake this slowing of our mental …

IS YOUR MEMORY DECLINE DUE TO ALZHEIMER’S DISEASE OR PART OF THE AGING PROCESS? Read More »

The innovative research conducted at the Bradenton Research Center is vital to both medical advances and unsurpassed patient care. The main objective of these clinical research trials is to answer questions about the safety and effectiveness of potential new medications. These studies must be completed before a new treatment can be offered to the public. Located in …

HEALTH MATTERS, BECAUSE YOU MATTER, AND CLINICAL RESEARCH MATTERS, TOO! Read More »

People with Multiple Sclerosis can experience a variety of symptoms, including problems with vision, bladder control, arm or leg movement, sensation, or balance. Research has proven that heat and humidity can often aggravate common symptoms of MS, and that cooling the body can help lessen these negative effects. We all know that living in the …

RELAPSING MS: DO WE HAVE A RESEARCH STUDY THAT’S RIGHT FOR YOU? Read More »

Parkinson’s disease is a progressive (gets worse over time) nervous system disorder that not only affects movement, but also a wide range of other functions, including mood, mental function and various bodily functions. Both the pace of progression and the range of symptoms are highly variable from person to person. There are an estimated 7 …

WE’RE SEEKING YOUR HELP FOR VOLUNTEERS WITH EARLY-STAGE PARKINSON’S DISEASE Read More »

Some of the earliest signs of neurodegeneration (inflammation, proteinopathy and neuronal atrophy), including that seen in Alzheimer’s and Parkinson’s diseases, occur in the locus coeruleus (LC, literally ‘blue place’) named for the bluish color of accumulated transmitter metabolites. This important brain stem nucleus is the origin of all ascending transmission by noradrenaline (also known as …

ALZHEIMER’S AND PARKINSON’S: POTENTIAL FOR REVERSING DISEASE PROGRESSION Read More »

Alzheimer’s disease is linked to the build-up of an abnormal protein in the brain called amyloid beta. Early on, this process doesn’t cause any obvious symptoms. But later, cognitive problems such as memory loss may emerge. The question is, could targeting amyloid beta prevent this? To answer this question and more, we need your help. …

COULD YOU HELP US IN THE FIGHT AGAINST ALZHEIMER’S DISEASE? Read More »